Ph.D.

MD Anderson study shows key enzyme linked to therapy resistance in deadly lung cancer

Mien-Chie Hung, Ph.D.

Two existing therapies may have potential for further study in treatment of EGFR-mutant non-small cell lung cancers Researchers at The University of Texas MD Anderson Cancer Center have identified a link between an enzyme tied to cancer formation and therapy resistance in patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC). They believe two existing therapies may hold promise for clinical studies for this deadly and common lung cancer for which relapse often occurs […]

Sarah P. Bernhardt, Ph.D., Named President & Ceo Of The Bayou Preservation Association

HOUSTON (August 20, 2018) – The Bayou Preservation Association has named Sarah P. Bernhardt, Ph.D., as its new President & CEO, effective immediately. She will lead the organization in realizing its vision of a network of healthy bayous, streams and watersheds through conservation, preservation, restoration and responsible watershed management. As head of the nonprofit, she will work in strategic partnership with the board of directors, advocate for its mission, programs and projects and help develop science-based […]

Genetically enhanced, cord-blood derived immune cells strike B-cell cancers

HOUSTON – Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers at The University of Texas MD Anderson Cancer Center report in the journal Leukemia. The team’s preclinical research shows that natural killer cells derived from donated umbilical cords can be modified to seek and destroy some types of leukemia and […]